Alexandrov A, Köhrmann M, Soinne L, Tsivgoulis G, Barreto AD, Demchuk AM, Sharma VK, Mikulik R, Muir KW, Brandt G, Alleman J, Grotta JC, Levi CR, Molina CA, Saqqur M, Mavridis D, Psaltopoulou T, Vosko M, Fiebach JB, Mandava P, Kent TA, Alexandrov AW, Schellinger PD (2019)
Publication Type: Journal article
Publication year: 2019
Book Volume: 18
Pages Range: 338-347
Journal Issue: 4
DOI: 10.1016/s1474-4422(19)30026-2
Background Pulsed-wave ultrasound increases the exposure of an intracranial thrombus to alteplase (recombinant tissue plasminogen activator), potentially facilitating early reperfusion. We aimed to ascertain if a novel operator-independent transcranial ultrasound device delivering low-power high-frequency ultrasound could improve functional outcome in patients treated with alteplase after acute ischaemic stroke.
APA:
Alexandrov, A., Köhrmann, M., Soinne, L., Tsivgoulis, G., Barreto, A.D., Demchuk, A.M.,... Schellinger, P.D. (2019). Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial. Lancet Neurology, 18(4), 338-347. https://doi.org/10.1016/s1474-4422(19)30026-2
MLA:
Alexandrov, Andrei, et al. "Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial." Lancet Neurology 18.4 (2019): 338-347.
BibTeX: Download